FMP

FMP

Enter

VIVO - Meridian Bioscience,...

photo-url-https://images.financialmodelingprep.com/symbol/VIVO.png

Meridian Bioscience, Inc.

VIVO

NASDAQ

Inactive Equity

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.

33.97 USD

0 (0%)

vivo Financial Statements

Year

2022

2021

2020

2019

Total Revenue

333.02M

317.9M

253.67M

201.01M

Cost of Revenue

144.66M

116.75M

97.42M

82.69M

Gross Profit

188.36M

201.15M

156.25M

118.33M

Operating Expenses

112.41M

107.63M

96.64M

80.98M

Research and Development

24.34M

23.91M

23.73M

17.95M

Selling, General & Administrative Expenses

88.42M

79.12M

72.91M

63.03M

Selling & Marketing Expenses

31.27M

26.78M

26.49M

28.45M

General & Administrative Expenses

57.15M

52.34M

46.42M

34.59M

Other Expenses

-350k

4.6M

0

0

Operating Income

55.51M

93.03M

61.32M

32.7M

Total Other Income/Expenses Net

-1.19M

-2.58M

-2.03M

-1.14M

Income Before Tax

54.32M

90.45M

59.29M

31.56M

Income Tax

11.86M

19.04M

13.11M

7.17M

Net Income

42.46M

71.41M

46.19M

24.38M

Basic EPS

0.96

1.62

1.07

0.57

EPS Diluted

0.96

1.62

1.07

0.57

Basic Average Shares

44.01M

44.01M

43.17M

42.9M

Diluted Average Shares

44.01M

44.01M

43.17M

42.9M

EBITDA

72.02M

107.61M

75.49M

43.47M

Retained Earning Schedule

Year

2022

2021

2020

2019

Retained Earnings (Previous Year)

180.7M

109.29M

63.11M

49.6M

Net Income

42.46M

71.41M

46.19M

24.38M

Stock Repurchases

0

0

0

0

Dividend Paid

0

0

0

-10.61M

Retained Earnings

223.16M

180.7M

109.29M

63.11M

Other Distributions

42.46M

71.41M

46.19M

2.89M

PPE Schedule

Year

2022

2021

2020

2019

Gross PPE

50.71M

49M

37.46M

30.57M

Annual Depreciation

16.51M

15.29M

13.57M

9.96M

Capital Expenditure

-8.62M

-18.31M

-3.3M

-3.8M

Net PPE

42.81M

52.03M

27.19M

24.4M

Intangible and Goodwill Schedule

Year

2022

2021

2020

2019

Acquisitions and Adjustments

1.63M

482k

24.95M

34.6M

Goodwill (Previous Year)

114.67M

114.19M

89.24M

54.64M

Goodwill

116.3M

114.67M

114.19M

89.24M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep